These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122. Sphingosine kinase 1 in breast cancer. Geffken K; Spiegel S Adv Biol Regul; 2018 Jan; 67():59-65. PubMed ID: 29055687 [TBL] [Abstract][Full Text] [Related]
123. SKI-178: A Multitargeted Inhibitor of Sphingosine Kinase and Microtubule Dynamics Demonstrating Therapeutic Efficacy in Acute Myeloid Leukemia Models. Hengst JA; Dick TE; Sharma A; Doi K; Hegde S; Tan SF; Geffert LM; Fox TE; Sharma AK; Desai D; Amin S; Kester M; Loughran TP; Paulson RF; Claxton DF; Wang HG; Yun JK Cancer Transl Med; 2017; 3(4):109-121. PubMed ID: 28890935 [TBL] [Abstract][Full Text] [Related]
124. The apoptotic mechanism of action of the sphingosine kinase 1 selective inhibitor SKI-178 in human acute myeloid leukemia cell lines. Dick TE; Hengst JA; Fox TE; Colledge AL; Kale VP; Sung SS; Sharma A; Amin S; Loughran TP; Kester M; Wang HG; Yun JK J Pharmacol Exp Ther; 2015 Mar; 352(3):494-508. PubMed ID: 25563902 [TBL] [Abstract][Full Text] [Related]
125. Effects of inhibition of serine palmitoyltransferase (SPT) and sphingosine kinase 1 (SphK1) on palmitate induced insulin resistance in L6 myotubes. Mikłosz A; Łukaszuk B; Baranowski M; Górski J; Chabowski A PLoS One; 2013; 8(12):e85547. PubMed ID: 24376889 [TBL] [Abstract][Full Text] [Related]
126. Bioactive lipids S1P and C1P are prometastatic factors in human rhabdomyosarcoma, and their tissue levels increase in response to radio/chemotherapy. Schneider G; Bryndza E; Abdel-Latif A; Ratajczak J; Maj M; Tarnowski M; Klyachkin YM; Houghton P; Morris AJ; Vater A; Klussmann S; Kucia M; Ratajczak MZ Mol Cancer Res; 2013 Jul; 11(7):793-807. PubMed ID: 23615526 [TBL] [Abstract][Full Text] [Related]
127. [Sphingosine kinase 1 and tumor]. Zhang CX; He HW; Shao RG Yao Xue Xue Bao; 2013 Jul; 48(7):971-8. PubMed ID: 24133963 [TBL] [Abstract][Full Text] [Related]
128. Targeting sphingosine kinase 1 in carcinoma cells decreases proliferation and survival by compromising PKC activity and cytokinesis. Kotelevets N; Fabbro D; Huwiler A; Zangemeister-Wittke U PLoS One; 2012; 7(6):e39209. PubMed ID: 22761740 [TBL] [Abstract][Full Text] [Related]
129. PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA). Johnson KR; Becker KP; Facchinetti MM; Hannun YA; Obeid LM J Biol Chem; 2002 Sep; 277(38):35257-62. PubMed ID: 12124383 [TBL] [Abstract][Full Text] [Related]
130. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. Nagahashi M; Ramachandran S; Kim EY; Allegood JC; Rashid OM; Yamada A; Zhao R; Milstien S; Zhou H; Spiegel S; Takabe K Cancer Res; 2012 Feb; 72(3):726-35. PubMed ID: 22298596 [TBL] [Abstract][Full Text] [Related]
131. Intracellular generation of sphingosine 1-phosphate in human lung endothelial cells: role of lipid phosphate phosphatase-1 and sphingosine kinase 1. Zhao Y; Kalari SK; Usatyuk PV; Gorshkova I; He D; Watkins T; Brindley DN; Sun C; Bittman R; Garcia JG; Berdyshev EV; Natarajan V J Biol Chem; 2007 May; 282(19):14165-77. PubMed ID: 17379599 [TBL] [Abstract][Full Text] [Related]
133. S1P lyase regulates DNA damage responses through a novel sphingolipid feedback mechanism. Kumar A; Oskouian B; Fyrst H; Zhang M; Paris F; Saba JD Cell Death Dis; 2011 Feb; 2(2):e119. PubMed ID: 21368890 [TBL] [Abstract][Full Text] [Related]
135. Loss of sphingosine kinase-1 in carcinoma cells increases formation of reactive oxygen species and sensitivity to doxorubicin-induced DNA damage. Huwiler A; Kotelevets N; Xin C; Pastukhov O; Pfeilschifter J; Zangemeister-Wittke U Br J Pharmacol; 2011 Jan; 162(2):532-43. PubMed ID: 20883472 [TBL] [Abstract][Full Text] [Related]